Detalles de la búsqueda
1.
Persistence of monoclonal B-cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus-associated lymphoproliferative disorders.
Br J Haematol
; 203(2): 237-243, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491625
2.
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma.
Hematol Oncol
; 38(4): 439-445, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495944
3.
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas.
Hum Pathol
; 136: 44-55, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36997030
4.
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.
Leukemia
; 37(4): 914-918, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807650
5.
IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study.
Leukemia
; 36(11): 2719-2723, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36127510
6.
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting.
Leuk Res
; 104: 106552, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33689920
Resultados
1 -
6
de 6
1
Próxima >
>>